Bio Green Med Solution (BGMS) Shares Outstanding (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Shares Outstanding (Entity) of $5.5 million for Q1 2026, up 1411.22% year-over-year from $365231.0 in Q1 2025, and up 152.6% quarter-over-quarter from $2.2 million in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Shares Outstanding (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Shares Outstanding (Entity) for 17 consecutive years, with $5.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 1411.22% year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $5.5 million (up 1411.22% YoY), while the FY2025 annual figure was $2.2 million, up 9692.39% from the prior year.
- Shares Outstanding (Entity) rose to $5.5 million in Q1 2026 per BGMS's latest filing, from $2.2 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $5.5 million in Q1 2026 and bottomed at $2776.0 in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $780071.9 across 5 years, with a median of $3554.0 in 2023.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) declined 0.78% — and 2025, when it surged 10468.03%.
- Bio Green Med Solution's Shares Outstanding (Entity) stood at $3483.0 in 2022, then gained by 2.04% to $3554.0 in 2023, then jumped by 527.86% to $22314.0 in 2024, then jumped by 9692.39% to $2.2 million in 2025, then jumped by 152.6% to $5.5 million in 2026.
- Business Quant data shows BGMS's Shares Outstanding (Entity) at $5.5 million in Q1 2026, $2.2 million in Q4 2025, and $1.9 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 61.30 Mn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | 398.00 Mn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | 210.89 Mn |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 111.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 445.06 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 5.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.60 Mn |
| Mar 31, 2026 | 5.46 Mn |
| Dec 31, 2025 | 2.19 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 365,231.00 |
| Dec 31, 2024 | 22,315.00 |
| Sep 30, 2024 | 44,681.00 |
| Jun 30, 2024 | 3,545.00 |
| Mar 31, 2024 | 3,545.00 |
| Dec 31, 2023 | 3,545.00 |
| Sep 30, 2023 | 3,307.00 |
| Jun 30, 2023 | 3,487.00 |
| Mar 31, 2023 | 3,483.00 |
| Dec 31, 2022 | 3,127.00 |
| Sep 30, 2022 | 3,421.00 |
| Jun 30, 2022 | 2,816.00 |
| Mar 31, 2022 | 2,776.00 |
| Dec 31, 2021 | 2,480.00 |
| Sep 30, 2021 | 2,602.00 |